Factors Favoring the Development of Chronic Subdural Hematoma After Traumatic Acute Subdural Hematoma in the Elderly

Tarik Wasfie1, Nicholas Fitzpatrick1, Mursal Niasan1

  • 1Department of Surgery/Trauma Section, 3577Ascension Genesys Hospital, Grand Blanc, MI, USA.

The American Surgeon
|November 19, 2021
PubMed

Insights

Elderly patients with traumatic acute subdural hematoma (TASDH) who are discharged home face increased risk of developing chronic subdural hematoma (CSDH). Diabetes, race, and disposition impact this risk, necessitating close follow-up.

Area of Science:

  • Neurosurgery
  • Geriatric Medicine
  • Trauma Surgery

Background:

  • Traumatic acute subdural hematoma (TASDH) is a common TBI in the elderly.
  • A subset of patients treated conservatively for TASDH may develop chronic subdural hematoma (CSDH).
  • Risk factors for CSDH development in elderly patients with TASDH are not well-established.

Purpose of the Study:

  • To identify risk factors associated with the progression of TASDH to CSDH in elderly patients.
  • To analyze data from elderly patients admitted with TASDH to determine predictors of subsequent CSDH.

Main Methods:

  • Retrospective analysis of 254 elderly patients with TASDH (2012-2016).
  • Comparison of patients readmitted with CSDH (Group A) versus those not readmitted (Group B).
  • Logistic regression analysis to identify significant risk factors (P ≤ .05).

Main Results:

  • 14.6% of patients underwent initial surgery; 5.6% were readmitted with CSDH within two months.
  • Significant risk factors for CSDH development included diabetes, race, and initial disposition to home.
  • Patients on anticoagulant therapy who developed CSDH required emergency craniotomy.

Conclusions:

  • Diabetes, race, and discharge disposition are potential risk factors for CSDH development after TASDH in the elderly.
  • Close clinical and radiographic follow-up is recommended for elderly patients post-discharge, especially those on anticoagulants.
  • Further research is needed due to the small sample size of patients who developed CSDH.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
24
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
23
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
14
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
10
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
16
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
370